Scilex Holding Company Proceeds from (Repayments of) Related Party Debt
Scilex Holding Company (SCLX) reported Proceeds from (Repayments of) Related Party Debt of -$125.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2022-02-24
- Scilex Holding Company proceeds from (repayments of) related party debt for the quarter ending 2021-12-31 was $0.00.
- Scilex Holding Company proceeds from (repayments of) related party debt for the quarter ending 2021-09-30 was $125.00K.
- Scilex Holding Company proceeds from (repayments of) related party debt for the quarter ending 2021-06-30 was -$125.00K.
- Scilex Holding Company proceeds from (repayments of) related party debt for the quarter ending 2021-03-31 was -$125.00K.
- Scilex Holding Company proceeds from (repayments of) related party debt for fiscal 2021 was -$125.00K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-02-24 | $125.00K derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | -$125.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $125.00K derived: 10-K 12 month − 3 quarters · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | -$125.00K 10-Q/A · filed 2021-12-08 | |
| 2021-06-30 | -$125.00K 10-Q/A · filed 2021-08-24 | -$250.00K derived: sum of 2 quarters · filed 2021-08-24 | ||
| 2021-03-31 | -$125.00K 10-Q · filed 2021-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |